PubMed:10021369 JSONTXT 7 Projects

Annnotations TAB TSV DIC JSON TextAE

Id Subject Object Predicate Lexical cue
T1 18-22 Protein denotes APC2
T2 43-87 Protein denotes adenomatous polyposis coli tumour suppressor
T3 93-151 Protein denotes adenomatous polyposis coli (APC) tumour-suppressor protein
E3 152-160 RegulatoryProcess denotes controls
T8 165-168 Protein denotes Wnt
E4 169-187 SignalingPathway denotes signalling pathway
T11 201-208 ProteinComplex denotes complex
T13 246-255 Enzyme denotes GSK-3beta
T14 258-272 Protein denotes axin/conductin
T15 277-288 Protein denotes betacatenin
T16 290-297 ProteinComplex denotes Complex
E7 308-315 PositiveRegulation denotes induces
E8 326-337 ProteinCatabolism denotes degradation
T20 341-352 Protein denotes betacatenin
T4 357-372 Tissue denotes colon carcinoma
T5 373-378 Cell denotes cells
E9 380-384 Decrease denotes loss
T23 388-391 Protein denotes APC
E1 392-397 PositiveRegulation denotes leads
E10 405-417 Increase denotes accumulation
T25 421-432 Protein denotes betacatenin
T26 440-447 Nucleus denotes nucleus
E11 458-463 BindingToProtein denotes binds
E12 471-480 PositiveRegulation denotes activates
T17 485-511 TranscriptionFactor denotes Tcf-4 transcription factor
T31 595-598 Protein denotes APC
T32 611-620 Eukaryote denotes Mammalian
T33 621-625 Protein denotes APC2
T34 651-654 Protein denotes APC
T35 666-682 ProteinDomain denotes domain structure
T36 735-747 ProteinDomain denotes SAMP domains
E13 780-787 BindingToProtein denotes binding
T38 791-800 Protein denotes conductin
T39 807-810 Protein denotes APC
T40 812-816 Protein denotes APC2
E14 817-826 RegulatoryProcess denotes regulates
E15 831-840 FormationOfTranscriptionFactorComplex denotes formation
T43 851-862 Protein denotes betacatenin
T44 863-866 Protein denotes Tcf
T45 867-876 ProteinComplex denotes complexes
E16 910-925 Transcription denotes transcriptional
E17 926-936 PositiveRegulation denotes activation
T55 937-943 ExperimentalMethod denotes assays
T48 947-950 Protein denotes APC
T6 955-970 Tissue denotes colon carcinoma
T21 971-976 Cell denotes cells
T50 978-983 Eukaryote denotes Human
T51 984-988 Protein denotes APC2
T52 997-1015 Chromosome denotes chromosome 19p13.3
T53 1017-1020 Protein denotes APC
T54 1025-1029 Protein denotes APC2
T49 1060-1069 Function denotes functions
E18 1073-1084 DevelopmentalProcess denotes development
E19 1089-1095 Disease denotes cancer
R1 T33 T36 hasPart APC2,SAMP domains
R10 T45 T44 hasPart complexes,Tcf
R11 T21 T6 locatedIn cells,colon carcinoma
R12 T51 T52 locatedIn APC2,chromosome 19p13.3
R13 T51 T50 fromSpecies APC2,Human
R14 T54 T49 hasFunction APC2,functions
R15 T53 T49 hasFunction APC,functions
R16 T11 T13 hasPart complex,GSK-3beta
R17 E9 T5 locatedIn loss,cells
R18 T3 E3 hasAgent adenomatous polyposis coli (APC) tumour-suppressor protein,controls
R19 E4 E3 hasPatient signalling pathway,controls
R20 T16 E7 hasAgent Complex,induces
R21 E8 E7 hasPatient degradation,induces
R22 T20 E8 hasPatient betacatenin,degradation
R23 T48 T21 locatedIn APC,cells
R23 T23 E9 hasPatient APC,loss
R24 T25 E10 hasPatient betacatenin,accumulation
R25 T17 E11 hasPatient Tcf-4 transcription factor,binds
R26 T17 E12 hasPatient Tcf-4 transcription factor,activates
R28 T38 E13 hasPatient conductin,binding
R29 T40 E14 hasAgent APC2,regulates
R3 T11 T14 hasPart complex,axin/conductin
R30 E15 E14 hasPatient formation,regulates
R31 T45 E15 hasPatient complexes,formation
R32 E16 E17 hasPatient transcriptional,activation
R33 E9 E1 hasAgent loss,leads
R34 E10 E1 hasPatient accumulation,leads
R4 T11 T15 hasPart complex,betacatenin
R5 T5 T4 locatedIn cells,colon carcinoma
R6 T11 T3 hasPart complex,adenomatous polyposis coli (APC) tumour-suppressor protein
R7 E10 T26 locatedIn accumulation,nucleus
R8 T33 T32 fromSpecies APC2,Mammalian
R9 T45 T43 hasPart complexes,betacatenin